Skip to main content

The market for scar and striae treatments is broad and deep.

Chances are that most of your current and prospective patients have scars, stretch marks, or both.1,2

95% 
of women are affected by Striae either during puberty or pregnancy

90% 
of all pregnant women develop stretch marks either on their breasts and/or abdomen by the third trimester

~ 17 million
patients receive scar treatments per year3,4

elos plus
Nordlys
Picoway
Vbeam Prima
TOP CONSIDERATIONS

Ask these vital questions before you invest in any device.

Will the device yield a strong return on your investment by:

  • Delivering consistent, superior performance?
  • Enabling you to treat a broad range of skin types?
  • Maximizing the number of spot sizes you can treat? 
  • Providing a comfortable treatment for your patients? 
  • Enhancing productivity with a user-friendly, intuitive interface?
  • Offering the versatility to treat a wide range of indications in addition to scars and striae?
TOP CONSIDERATIONS

Ask these vital questions before you invest in any device.

Can you count on the manufacturer to:

  • Provide a highly recognized brand that will enhance your practice?
  • Demonstrate a track record of proven science, real results, and well-earned trust?
  • Deliver outstanding service and support by highly trained technicians?
  • Be your constant source for innovative, gold standard solutions? 
  • Help you stay abreast of the latest technology and industry thought leadership? 
  • Furnish robust, effective, on-site clinical training?
  • Supply patient-friendly marketing materials to help your practice grow?
  • Be there for you as your trusted partner, now and in the future?

Could reducing scars and striae help increase your practice’s revenues?

Products
/sites/default/files/2019-02/4-3_products_elosplus_0.jpg
/sites/default/files/2019-02/4-3_products_etwo_0.jpg
/sites/default/files/2019-02/4-3_products_picoway_0.jpg
/sites/default/files/2019-02/4-3_products_vbeamprima.jpg

Built on a legacy of trust. 

  1. Gauglitz GG, Korting HC, Pavicic T, et al. Hypertrophic Scarring and Keloids: Pathomechanisms and Current and Emerging Treatment Strategies. Mol Med. 2011 Jan-Feb; 17(1-2): 113–125. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022978/. Accessed on <Month date>, 2019.
  2. Stretch marks getting under your skin? CBS News. 4 March 2009. Available at: https://www.cbsnews.com/news/stretch-marks-getting-under-your-skin-04-03-2009/. Accessed on <Month date>, 2019.
  3. 2013 U.S. Census Bureau, Population Division, June 2014 
  4. Internal Syneron Candela Estimation 
  5. Gozali MV, Zhou B. Effective treatments of atrophic acne scars. J Clin Aesthet Dermatol. 2015 May; 8(5): 33–40. Available at:  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445894/. Accessed on <Month date>, 2019.
  6. Sund B [Clinical Report]. In: New developments in wound care, vol. 86. London: PJB Publications CBS; 2000. pp. 1-255.
  7. Young VL, Hutchison J. Insights into patient and clinician concerns about scar appearance: semiquantitative structured surveys. Plast Reconstr Surg 2009;124:256-65. Available at: https://www.ncbi.nlm.nih.gov/pubmed/19568089. Accessed on <Month date>, 2019.